Physician profile
Stanley C Hall
NPI 1003815259
$7,669.09
in general payments reported to CMS, 2019-2025
44 companies · $2,434 in 2025
The $2,434 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,174 · 2020: $142 · 2021: $204 · 2022: $525 · 2023: $761 · 2024: $2,430 · 2025: $2,434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,837 · Travel and Lodging: $1,717 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,837.21 |
| Travel and Lodging | $1,717.16 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $864.74 | 2021-2025 | Urolift, Barrigel |
| Angiodynamics, INC. | $702.17 | 2024-2025 | Nanoknife |
| Boston Scientific Corporation | $676.98 | 2019-2025 | Rezum Generator |
| Axonics, INC. | $596.81 | 2023-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $407.99 | 2019-2025 | Erleada |
| Urogen Pharma, INC. | $334.00 | 2023-2025 | Jelmyto |
| Astellas Pharma US INC | $326.46 | 2019-2023 | Myrbetriq, Veozah |
| Procept Biorobotics Corporation | $319.21 | 2022-2025 | Aquabeam System |
| Endo Pharmaceuticals INC. | $288.87 | 2019-2024 | Xiaflex |
| Abbvie INC. | $261.36 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $252.48 | 2024-2025 | Provenge |
| Pfizer INC. | $245.11 | 2019-2025 | |
| Endo USA, INC. | $244.68 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $223.83 | 2024-2025 | Adstiladrin |
| Coloplast Corp | $220.68 | 2019-2025 | Speedicath |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $216.14 | 2023-2025 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $206.70 | 2024-2025 | Keytruda, Zerbaxa, Keytruda Qlex |
| Myriad Genetic Laboratories, INC. | $121.36 | 2023-2024 | Prolaris |
| Karl Storz Lithotripsy-America | $119.32 | 2019 | |
| Laborie Medical Technologies Corp. | $94.41 | 2024-2025 | Urgent PC Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter |
| Progenics Pharmaceuticals, INC. | $90.44 | 2023-2025 | Pylarify |
| Sun Pharmaceutical Industries INC. | $82.88 | 2024-2025 | |
| Accord Healthcare, INC. | $75.17 | 2025 | |
| 180 Medical, INC. | $71.09 | 2019-2025 | Gentlecath Glide |
| Abc Home Medical Supply, INC. | $61.54 | 2022-2025 | |
| Abbott Laboratories | $55.64 | 2019-2023 | Axium |
| Bayer Healthcare Pharmaceuticals INC. | $54.47 | 2024-2025 | |
| Blue Earth Diagnostics | $46.01 | 2019-2025 | Posluma |
| Immunitybio, INC. | $43.13 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $38.83 | 2025 | Bard Urinary Drainage Bag |
| Allergan, INC. | $37.89 | 2019 | |
| Convatec INC. | $36.25 | 2024-2025 | |
| Medtronic, INC. | $35.51 | 2025 | Interstim |
| Tolmar, INC. | $29.85 | 2025 | Jatenzo, Eligard |
| Neotract INC. | $28.29 | 2019-2020 | |
| Profound Medical Corp. | $23.56 | 2025 | Tulsa-Pro |
| Antares Pharma, INC. | $21.30 | 2024 | Xyosted |
| Integra Lifesciences Corporation | $21.00 | 2021 | |
| Urovant Sciences INC | $19.04 | 2022 | |
| Mission Pharmacal Company | $16.82 | 2020 | |
| Civco Medical Instruments | $16.73 | 2025 | |
| Myovant Sciences INC. | $15.32 | 2022 | |
| Photocure INC | $13.88 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.